Here's the full No-Code market picture. 1055 launches indexed, broken down by year, quarter, and engagement metrics. Use this to understand where the category has been and where it's heading.
Five years of No-Code launch data. Volume, engagement, and the products that stood out.
Here's the full No-Code market picture. 1055 launches indexed, broken down by year, quarter, and engagement metrics. Use this to understand where the category has been and where it's heading.
| Quarter | Launches | Avg Interest Score | Top Product |
|---|---|---|---|
| Q1 2026 | 35 | 151 | Needle 2.0 |
| Q2 2026 | 2 | 14 | AppDeploy |
| Q1 2025 | 39 | 169 | Lovable + Builder.io |
| Q2 2025 | 56 | 162 | Pythagora 2.0 |
| Q3 2025 | 51 | 283 | Trace |
| Q4 2025 | 37 | 164 | Loki.Build |
| Q1 2024 | 57 | 235 | Butternut AI 1.0 |
| Q2 2024 | 37 | 215 | deco.cx 2.0 |
| Q3 2024 | 45 | 179 | Epsilla |
| Q4 2024 | 29 | 273 | HeyForm 3.0 |
| Q1 2023 | 75 | 190 | Bento |
| Q2 2023 | 89 | 197 | Dora AI (Alpha) |
| Q3 2023 | 88 | 184 | Tally 2.0 |
| Q4 2023 | 71 | 174 | FuseBase |
| Q1 2022 | 43 | 233 | Clay |
| Q2 2022 | 43 | 158 | Folk |
The No-Code category has been cooling over the past 6 years of tracked data. Total launches went from 161 in 2021 to 37 in 2026.
Average engagement ratio across all No-Code launches: 0.30. Products above that line tend to solve a specific, painful problem. Products below it often entered a crowded space without clear differentiation.
No-Code peaked in 2023 with 323 launches. That was 3 years ago. The decline since then could signal market consolidation, saturation, or attention shifting to adjacent categories.
Average engagement per product has risen from 0.32 in 2021 to 0.35 in 2026. That upward trend means the community is spending more time with each new launch. Either the products are getting better, or the audience is getting more selective. Probably both.
The highest-performing quarter was Q3 2025, with an average interest score of 283 across 51 launches. Trace led that quarter.
1055 B2B launches (100%) vs 0 B2C (0%) across the full No-Code dataset. No-Code is heavily B2B. The products here target teams, companies, and professional workflows.
2021: 161 launches. Average interest: 217. Average engagement: 0.32. Top launch: Typedream (1,421 interest).
2022: 183 launches (+14% vs 2021). Average interest: 184. Average engagement: 0.26. Top launch: Folk (1,190 interest).
2023: 323 launches (+77% vs 2022). Average interest: 187. Average engagement: 0.27. Top launch: Tally 2.0 (1,444 interest).
2024: 168 launches (-48% vs 2023). Average interest: 222. Average engagement: 0.28. Top launch: Epsilla (1,067 interest).
2025: 183 launches (+9% vs 2024). Average interest: 198. Average engagement: 0.36. Top launch: Trace (1,568 interest).
2026: 37 launches (-80% vs 2025). Average interest: 144. Average engagement: 0.35. Top launch: Needle 2.0 (611 interest).
We report what happened. We don't predict. Five years of data shows patterns, but markets surprise people for a living.
Three common reasons. The market consolidated around winners. The technology matured and stopped generating new startups. Or builder attention shifted to adjacent categories. Usually it's a combination.
Volume without engagement is saturation. Engagement without volume is opportunity. Check which one you're looking at.
Sum of all interest scores in the quarter divided by number of products. Simple average. We don't weight by category or product age.
Depends on what's declining. If volume drops but engagement rises, the market is maturing. That's often good for existing players. If both drop, the category may be dying. The quarterly breakdown on each page tells you which pattern you're seeing.
At least three. Two data points is a line, not a trend. We have five years of data for most categories, which is enough to distinguish real shifts from noise.
Current year launches compared to the same period last year. Positive means more products launching. Negative means the category cooled. Neither is inherently good or bad. A mature category with fewer but better launches is often healthier than one flooding the market with clones.